在晚期胃神经内分泌癌的尼沃卢马布单一治疗中完全缓解
Koichiro Tajima1, Yuichi Shimodate1, Hirokazu Mouri1
1Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Japan.
Internal medicine (Tokyo, Japan)
|March 2, 2025
概括
这项研究报告了胃神经内分泌癌在使用nivolumab单一治疗的情况下完全缓解. 该患者经历了超过16个月的持续缓解,突出了潜在的治疗途径.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 胃神经内分泌癌 (GNEC) 是一种罕见的恶性瘤.
- 标准治疗通常具有有限的疗效,特别是在晚期.
- 息性手术和化疗是常见的治疗策略.
研究的目的:
- 报告一个晚期胃神经内分泌癌完全缓解的病例.
- 在耐火性GNEC病例中评估nivolumab单一治疗的疗效.
- 为了记录尼沃卢马布治疗后的长期结果.
主要方法:
- 患有大细胞GNEC的患者接受了化疗后的息性胃切除术 (碳白,乙胺).
- 用帕克利塔克塞尔和拉穆西鲁马布的救生疗法未能控制疾病的进展.
- 尼沃卢马布单一治疗被给予,随后由于免疫相关的不良事件而中止治疗.
主要成果:
- 尼沃卢马布单一治疗导致三个周期后完全缓解.
- 在停止尼沃卢马布治疗后,完全缓解持续至少16个月.
- 患者从开始尼沃卢马布治疗后存活了28个月.
结论:
- 尼沃卢马布单一治疗可以在晚期胃神经内分泌癌中实现完全和持久的缓解.
- 这一案例表明尼沃卢马布作为耐火性GNEC的可行治疗选择.
- 需要进一步的研究来探索在GNEC管理中的免疫疗法.
关键词:
卡博普拉丁是碳酸盐中的一种.胃癌 胃癌 是一种胃癌.神经内分泌癌瘤是一种神经内分泌癌.这就是尼沃卢马布 (nivolumab).帕克利塔克塞尔 (paclitaxel) 是一种药物.拉穆齐鲁姆巴布拉姆是什么意思更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.0K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.1K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
01:27Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461